BJ
OCUL icon

BlackRock Japan’s Ocular Therapeutix OCUL Stock Holding History

BlackRock Japan’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-348
Closed -$5K – 1363
2014
Q3 		$5K Buy
+348
New +$5.15K ﹤0.01% 1240

Other funds holding OCUL

SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock Japan's OCUL Position: Q4 2014 in Review

BlackRock Japan sold out of Ocular Therapeutix (OCUL) in Q4 2014, closing a stake of 348 shares — an estimated $5K sold.

BlackRock Japan first reported a position in OCUL in Q3 2014 and held it in 1 quarter. The position peaked at $5K in Q3 2014. 37 funds tracked by Wall St. Rank hold OCUL as of Q4 2014.

  • BlackRock Japan reported no remaining Ocular Therapeutix position as of Q4 2014 after selling out during the quarter.
  • BlackRock Japan sold 348 Ocular Therapeutix shares in Q4 2014, an estimated $5K.
  • BlackRock Japan first reported a position in Ocular Therapeutix in Q3 2014 and held it in 1 quarter.
  • BlackRock Japan's Ocular Therapeutix position peaked at $5K in Q3 2014.
  • 37 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q4 2014.

Based on BlackRock Japan's 13F filing for Q4 2014, filed 9 Feb 2015.